SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-012759
Filing Date
2021-05-24
Accepted
2021-05-24 17:26:58
Documents
47
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 338848
2 ex31-1.htm EX-31.1 15621
3 ex32-1.htm EX-32.1 7517
  Complete submission text file 0001493152-21-012759.txt   2214719

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE lung-20210331.xml EX-101.INS 279052
5 XBRL SCHEMA FILE lung-20210331.xsd EX-101.SCH 29722
6 XBRL CALCULATION FILE lung-20210331_cal.xml EX-101.CAL 37485
7 XBRL DEFINITION FILE lung-20210331_def.xml EX-101.DEF 106622
8 XBRL LABEL FILE lung-20210331_lab.xml EX-101.LAB 230824
9 XBRL PRESENTATION FILE lung-20210331_pre.xml EX-101.PRE 181278
Mailing Address 350 W. 800 N. SUITE 214 SALT LAKE CITY UT 84103
Business Address 350 W. 800 N. SUITE 214 SALT LAKE CITY UT 84103 (801) 736-0729
PROLUNG INC (Filer) CIK: 0001541884 (see all company filings)

IRS No.: 201922768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38362 | Film No.: 21956296
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences